Skip to main content
SpringerLink
Log in

Elevating Safe Use of Over-The-Counter Medications in Older Adults: A Narrative Review of Pharmacy Involved Interventions and Recommendations for Improvement

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Over-the-counter (OTC) medications are products that have been made easily accessible to allow patients to treat common ailments without a prescription and the cost of a doctor’s visit. These medications are generally considered safe; however, there is still a potential for these medications to lead to adverse health outcomes. Older adults (ages 50+) are especially susceptible to these adverse health outcomes, due to age-related physiological changes, a higher prevalence of comorbidities, and prescription medication use. Many OTC medications are sold in pharmacies, which provides pharmacists and technicians with the opportunity to help guide safe selection and use for these medications. Therefore, community pharmacies are the ideal setting for OTC medication safety interventions. This narrative review summarizes the findings of pharmacy-involved interventions that promote safe OTC medication use for older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007;29(Suppl):2477–97.

    CAS  PubMed  Google Scholar 

  2. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol. 2005;32:2218–24.

    CAS  PubMed  Google Scholar 

  3. Consumer Healthcare Products Association. 2022 OTC value study: OTC medicines save the US healthcare system $167B annually. [cited 2023 Mar 23]. https://www.chpa.org/about-consumer-healthcare/infographics/2022-otc-value-study-otc-medicines-save-us-healthcare-system-%24167B-annually.

  4. Consumer Healthcare Products Association. 2022 OTC value study: if OTC medicines weren’t available. [cited 2023 Mar 23]. https://www.chpa.org/about-consumer-healthcare/infographics/2022-otc-value-study-if-otc-medicines-werent-available.

  5. Consumer Healthcare Products Association. 2022 OTC value study: $7.33 saved for every $1 spent. [cited 2023 Mar 23]. https://www.chpa.org/about-consumer-healthcare/infographics/2022-otc-value-study-733-saved-every-1-spent.

  6. McElnay JC, McCallion CR. Non-prescription drug use by elderly patients. Int J Pharm Pract. 1996;4:12–8.

    Google Scholar 

  7. Paliwal Y, Gendron TL, Jones RM, Moczygemba L, Nadpara PA, Slattum PW. A qualitative study to understand over-the-counter medication use and decision-making among residents of senior-living communities. Res Soc Adm Pharm. 2019;15:730–7.

    Google Scholar 

  8. Barrenberg E, Garbe E. Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol. 2015;71:1389–96.

    CAS  PubMed  Google Scholar 

  9. Wawruch M, Kuzelova M, Foltanova T, Ondriasova E, Luha J, Dukat A, et al. Characteristics of elderly patients who consider over-the-counter medications as safe. Int J Clin Pharm. 2013;35:121–8.

    PubMed  Google Scholar 

  10. Mullan J, Weston KM, Bonney A, Burns P, Mullan J, Rudd R. Consumer knowledge about over-the-counter NSAIDs: they don’t know what they don’t know. Aust N Z J Public Health. 2017;41:210–4.

    PubMed  Google Scholar 

  11. Suppiah SD, Malhotra R, Tan YW, Jessup RL, Chew LST, Tang W-E, et al. Prevalence of health literacy and its correlates from a national survey of older adults. Res Soc Adm Pharm. 2023. https://www.sciencedirect.com/science/article/pii/S1551741123000700.

  12. Gilson AM, Stone JA, Morris AO, Brown RL, Xiong KZ, Jacobson N, et al. Impact of a pilot community pharmacy system redesign on reducing over-the-counter medication misuse in older adults. J Am Pharm Assoc. 2021;61:555–64.

    Google Scholar 

  13. Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38:2340–72.

    CAS  PubMed  Google Scholar 

  14. Albert SM, Roth T, Toscani M, Vitiello MV, Zee P. Sleep health and appropriate use of OTC sleep aids in older adults—recommendations of a Gerontological Society of America Workgroup. Gerontologist. 2017;57:163–70.

    PubMed  Google Scholar 

  15. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006;4:168–92.

    CAS  PubMed  Google Scholar 

  16. Almond SM, Warren MJ, Shealy KM, Threatt TB, Ward ED. A systematic review of the efficacy and safety of over-the-counter medications used in older people for the treatment of primary insomnia. Sr Care Pharm. 2021;36:83–92.

    PubMed  Google Scholar 

  17. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41:67–76.

    CAS  PubMed  Google Scholar 

  18. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5:263–303.

    CAS  PubMed  Google Scholar 

  19. Urbonas G, Kubilienė L. Assessing the relationship between pharmacists’ job satisfaction and over-the-counter counselling at community pharmacies. Int J Clin Pharm. 2016;38:252–60.

    PubMed  Google Scholar 

  20. Kebodeaux C, Grise W, Hudspeth B, Divine H. Chain community pharmacists’ willingness, attitudes, and barriers in providing self-care medication and supplement recommendations. SelfCare. 2012;3:21–32.

    Google Scholar 

  21. National Association of Chain Drug Stores (NACDS). Pharmacies—the face of neighborhood healthcare since well before the pandemic. 2022. https://www.nacds.org/news/nacds-releases-digital-content-illustrating-pharmacys-proven-value-now-and-in-the-future/.

  22. Tran AT, Soullier N, Ankri J, Herr M, Carcaillon-Bentata L. Uses and perceptions of medications among French older adults: results from the 2020 French Health Barometer survey. BMC Geriatr. 2022;22:602.

    PubMed  PubMed Central  Google Scholar 

  23. Hedenrud T, Andersson Sundell K, Martinsson J, Håkonsen H. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study. Int J Pharm Pract. 2019;27:17–24.

    PubMed  Google Scholar 

  24. Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. Consumption of over-the-counter drugs: prevalence and type of drugs. Int J Environ Res Public Health. 2021;18:5530.

    PubMed  PubMed Central  Google Scholar 

  25. Wójta-Kempa M, Krzyżanowski DM. Correlates of abusing and misusing over-the-counter pain relievers among adult population of Wrocław (Poland). Adv Clin Exp Med. 2016;25:349–60.

    PubMed  Google Scholar 

  26. Masumoto S, Sato M, Maeno T, Ichinohe Y, Maeno T. Factors associated with the use of dietary supplements and over-the-counter medications in Japanese elderly patients. BMC Fam Pract. 2018;19:20.

    PubMed  PubMed Central  Google Scholar 

  27. Błeszyńska-Marunowska E, Jagiełło K, Grodzicki T, Wierucki Ł, Sznitowska M, Kalarus Z, et al. Polypharmacy among elderly patients in Poland: prevalence, predisposing factors, and management strategies. Pol Arch Intern Med. 2022;132:16347.

    PubMed  Google Scholar 

  28. Harris DA, Guo Y, Nakhla N, Tadrous M, Hogan DB, Hennessy D, et al. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians. Health Rep. 2022;33:3–16.

    PubMed  Google Scholar 

  29. Chang J, Wang Q, Fang Y. Socioeconomic differences in self-medication among middle-aged and older people: data from the China health and retirement longitudinal study. BMJ Open. 2017;7: e017306.

    PubMed  PubMed Central  Google Scholar 

  30. Per BL, Taylor AW, Gill TK. Prescription medicines, over-the-counter medicines and complementary and alternative medicines use: a comparison between baby boomers and older South Australians. AIMS Public Health. 2019;6:380–95.

    PubMed  PubMed Central  Google Scholar 

  31. Maust DT, Solway E, Clark SJ, Kirch M, Singer DC, Malani P. Prescription and nonprescription sleep product use among older adults in the United States. Am J Geriatr Psychiatry. 2019;27:32–41.

    PubMed  Google Scholar 

  32. Koffeman AR, Valkhoff VE, Celik S, W’T Jong G, Sturkenboom MC, Bindels PJ, et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract. 2014;64: e191-8.

    PubMed  Google Scholar 

  33. Sheikh-Taha M, Dimassi H. Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA. BMC Geriatr. 2018;18:301.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Fielding S, Slovic P, Johnston M, Lee AJ, Bond CM, Watson MC. Public risk perception of non-prescription medicines and information disclosure during consultations: a suitable target for intervention? Int J Pharm Pract. 2018;26:423–32.

    PubMed  Google Scholar 

  35. Mhatre SK, Sansgiry SS. Assessing a conceptual model of over-the-counter medication misuse, adverse drug events and health-related quality of life in an elderly population. Geriatr Gerontol Int. 2016;16:103–10.

    PubMed  Google Scholar 

  36. Krüger C, Schäfer I, van den Bussche H, Baehr M, Bickel H, Fuchs A, et al. Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: data of the exploratory analysis of the multicentre, observational cohort study MultiCare. Eur J Gen Pract. 2021;27:119–29.

    PubMed  PubMed Central  Google Scholar 

  37. Chun SY, Park HK, Han KT, Kim W, Lee HJ, Park EC. Deregulation of sale of over-the-counter drugs outside of pharmacies in the Republic of Korea: interrupted-time-series analysis of outpatient visits before and after the policy. BMC Health Serv Res. 2017;17:478.

    PubMed  PubMed Central  Google Scholar 

  38. Woron J, Chrobak A, Slezak D, Siwek M. Unprescribed and unnoticed: retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs. Front Pharmacol. 2022;13.

  39. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society. Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674–94.

    Google Scholar 

  40. Stone JA, Lester CA, Aboneh EA, Phelan CH, Welch LL, Chui MA. A preliminary examination of over-the-counter medication misuse rates in older adults. Res Soc Adm Pharm. 2017;13:187–92.

    Google Scholar 

  41. Zeenny R, Wakim S, Kuyumjian Y-M. Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging. 2017;65–73.

  42. Abraham O, Schleiden L, Albert SM. Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep. Int J Clin Pharm. 2017;39:808–17.

    PubMed  PubMed Central  Google Scholar 

  43. Mullen RJ, Curtis LM, O’Conor R, Serper M, McCarthy D, Bailey SC, et al. Visual acuity, literacy, and unintentional misuse of nonprescription medications. Am J Health Syst Pharm. 2018;75:e213–20.

    PubMed  Google Scholar 

  44. Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger KE. Prevalence and patient awareness of selected potential drug interactions with self-medication. J Clin Pharm Ther. 2007;32:149–59.

    CAS  PubMed  Google Scholar 

  45. Stone JA, Phelan CH, Holden RJ, Jacobson N, Chui MA. A pilot study of decision factors influencing over-the-counter medication selection and use by older adults. Res Soc Adm Pharm. 2020;16:1117–20.

    Google Scholar 

  46. Abraham O, Schleiden LJ, Brothers AL, Albert SM. Managing sleep problems using non-prescription medications and the role of community pharmacists: older adults’ perspectives. Int J Pharm Pract. 2017;25:438–46.

    PubMed  PubMed Central  Google Scholar 

  47. Morris AO, Gilson A, Chui MA, Xiong K. Utilizing a cognitive engineering approach to conduct a hierarchical task analysis to understand complex older adult decision-making during over-the-counter medication selection. Res Soc Adm Pharm. 2021;17:2116–26.

    Google Scholar 

  48. Maitah Y, Rana R, Vordenberg SE. Older adults experiencing polypharmacy preferred to continue their non-prescription products during a card sorting activity. Int J Pharm Pr. 2022;31:257–60.

    Google Scholar 

  49. Martin AM, Jones JN, Gilbert JE. A spoonful of sugar: understanding the over-the-counter medication needs and practices of older adults. PervasiveHealth 13. Brussels, Belgium; 2013.

  50. Martin-Hammond AM, Abegaz T, Gilbert JE. Designing an over-the-counter consumer decision-making tool for older adults. J Biomed Inf. 2015;57:113–23.

    Google Scholar 

  51. Pires CM, Cavaco AM. Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine. Eur J Clin Pharmacol. 2014;70:583–8.

    PubMed  Google Scholar 

  52. Tong V, Raynor DK, Aslani P. Comparative user testing of Australian and UK over-the-counter labels and leaflets for diclofenac. Ther Innov Regul Sci. 2018;52:38–48.

    PubMed  Google Scholar 

  53. Tong V, Raynor DK, Aslani P. Developing alternative over-the-counter medicine label formats: how do they compare when evaluated by consumers? Res Soc Adm Pharm. 2018;14:248–61.

    Google Scholar 

  54. Tong V, Raynor DK, Aslani P. “It’s all there in black and white”—or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format. Health Expect. 2016;19:948–61.

    PubMed  Google Scholar 

  55. Harben AL, Kashy DA, Esfahanian S, Liu L, Bix L, Becker MW. Using change detection to objectively evaluate whether novel over-the-counter drug labels can increase attention to critical health information among older adults. Cogn Res Princ Implic. 2021;6:40.

    PubMed  PubMed Central  Google Scholar 

  56. Wolf MS, Bailey SC, Serper M, Smith M, Davis TC, Russell AL, et al. Comparative effectiveness of patient-centered strategies to improve FDA medication guides. Med Care. 2014;52:781–9.

    PubMed  Google Scholar 

  57. Martin BA, Breslow RM, Sims A, Harben AL, Bix L, Becker MW. Identifying over-the-counter information to prioritize for the purpose of reducing adverse drug reactions in older adults: a national survey of pharmacists. J Am Pharm Assoc. 2022;62:167-175.e1.

    Google Scholar 

  58. Schimmelfing JT, Brookhart AL, Fountain KMB, Goode JKR. Pharmacist intervention in patient selection of nonprescription and self-care products. J Am Pharm Assoc. 2017;57:86-89.e1.

    Google Scholar 

  59. McConaha JL, Finoli LM, Heasley JE, Lunney PD. Assessing student pharmacist impact on patient over-the-counter medication selection. J Pharm Pract. 2013;26:280–7.

    PubMed  Google Scholar 

  60. Bosse N, Machado M, Mistry A. Efficacy of an over-the-counter intervention follow-up program in community pharmacies. J Am Pharm Assoc JAPhA. 2012;52:535–40 (5 p following 540).

    Google Scholar 

  61. Kennedy C, Duggan E, Bennett K, Williams DJ. Rates of reported codeine-related poisonings and codeine prescribing following new national guidance in Ireland. Pharmacoepidemiol Drug Saf. 2019;28:106–11.

    CAS  PubMed  Google Scholar 

  62. Cairns R, Brown JA, Buckley NA. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia’s largest poisons centre. Addict Abingdon Engl. 2016;111:1848–53.

    Google Scholar 

  63. McCoy J, Bruno R, Nielsen S. Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. Drug Alcohol Rev. 2018;37:257–61.

    PubMed  Google Scholar 

  64. Mishriky J, Stupans I, Chan V. Pharmacists’ views on the upscheduling of codeine-containing analgesics to “prescription only” medicines in Australia. Int J Clin Pharm. 2019;41:538–45.

    PubMed  Google Scholar 

  65. Carney T, Wells J, Bergin M, Dada S, Foley M, McGuiness P, et al. A comparative exploration of community pharmacists’ views on the nature and management of over-the-counter (OTC) and prescription codeine misuse in three regulatory regimes: Ireland, South Africa and the United Kingdom. Int J Ment Health Addict. 2016;14:351–69.

    Google Scholar 

  66. Mishriky J, Stupans I, Chan V. The views of Australian adults experiencing pain on the upscheduling of codeine-containing analgesics to ‘prescription only.’ Int J Clin Pharm. 2021;43:386–93.

    PubMed  Google Scholar 

  67. FDA. U.S. Food & Drug Administration. Legal Requirements for the Sale and Purchase of Drug Products Containing Pseudoephedrine, Ephedrine, and Phenylpropanolamine. 2017 [cited 2023 Mar 23]. https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and.

  68. Hattingh HL, Varsani J, Kachouei LA, Parsons R. Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study. Subst Abuse Treat Prev Policy. 2016;11:30.

    PubMed  PubMed Central  Google Scholar 

  69. Holden RJ, Srinivas P, Campbell NL, Clark DO, Bodke KS, Hong Y, et al. Understanding older adults’ medication decision making and behavior: a study on over-the-counter (OTC) anticholinergic medications. Res Soc Adm Pharm. 2019;15:53–60.

    Google Scholar 

  70. Chui MA, Stone JA, Holden RJ. Improving over-the-counter medication safety for older adults: a study protocol for a demonstration and dissemination study. Res Soc Adm Pharm. 2017;13:930–7.

    Google Scholar 

  71. Reddy A, Lester CA, Stone JA, Holden RJ, Phelan CH, Chui MA. Applying participatory design to a pharmacy system intervention. Res Soc Adm Pharm RSAP. 2019;15:1358–67.

    Google Scholar 

  72. Gilson AM, Xiong KZ, Stone JA, Jacobson N, Phelan C, Reddy A, et al. Improving patient–pharmacist encounters with over-the-counter medications: a mixed-methods pilot study. Innov Pharm. 2020;11:11.

    Google Scholar 

  73. Gilson AM, Xiong KZ, Stone JA, Jacobson N, Chui MA. A pharmacy-based intervention to improve safe over-the-counter medication use in older adults. Res Soc Adm Pharm. 2021;17:578–87.

    Google Scholar 

  74. Chui MA, Berbakov ME, Gilson AM, Morris AO, Stone JA. Effectiveness and sustainment of a tailored over-the-counter medication safety intervention in community pharmacies: a randomized controlled trial. Res Soc Adm Pharm. 2022;18:3953–63.

    Google Scholar 

  75. Chui MA, Stone JA, Martin BA, Croes KD, Thorpe JM. Safeguarding older adults from inappropriate over-the-counter medications: the role of community pharmacists. Gerontologist. 2014;54:989–1000.

    PubMed  Google Scholar 

  76. Watson MC, Bond CM, Grimshaw J, Johnston M. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care. 2006;15:53.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Davies JE, Barber N, Taylor D. What do community pharmacists do? Results from a work sampling study in London. Int J Pharm Pract. 2014;22:309–18.

    PubMed  Google Scholar 

  78. Cavaye D, Lehnbom EC, Laba TL, El-Boustani E, Joshi R, Webster R. Considering pharmacy workflow in the context of Australian community pharmacy: a pilot time and motion study. Res Soc Adm Pharm. 2018;14:1157–62.

    Google Scholar 

  79. Karia A, Norman R, Robinson S, Lehnbom E, Laba T-L, Durakovic I, et al. Pharmacist’s time spent: space for Pharmacy-based Interventions and Consultation TimE (SPICE)—an observational time and motion study. BMJ Open. 2022;12: e055597.

    PubMed  PubMed Central  Google Scholar 

  80. Gregório J, Cavaco AM, Lapão LV. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis. Res Soc Adm Pharm. 2017;13:133–47.

    Google Scholar 

  81. Gilson AM, Stone JA, Reddy A, Chui MA. Exploring how pharmacists engage with patients about over-the-counter medications. J Am Pharm Assoc. 2019;59:852–6.

    Google Scholar 

Download references

Acknowledgements

Thank you to Paije Wilson, Health Science Librarian at Ebling Library at the University of Wisconsin-Madison, who was vital in conducting the literature search. Thank you to the Systems Approach to Medication Safety (SAMS) lab for their support of this manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway

    Elin C. Lehnbom

  2. Department of Health and Caring Sciences, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden

    Elin C. Lehnbom

  3. Sonderegger Research Center, University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA

    Maria E. Berbakov, Emily L. Hoffins, Jukrin Moon & Michelle A. Chui

  4. William S. Middleton VA Geriatrics Research Education & Clinical Center, Madison, WI, USA

    Lauren Welch

  5. Social and Administrative Sciences Division, University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA

    Michelle A. Chui

Authors
  1. Elin C. Lehnbom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria E. Berbakov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emily L. Hoffins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jukrin Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lauren Welch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michelle A. Chui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle A. Chui.

Ethics declarations

Funding

No funding was received for the preparation of this article.

Conflicts of interests/competing interests

None of the authors have any conflicts of interest to disclose.

Author contributions

ECL performed the search and reviewed titles. ECL, MB, EH, JM and LW wrote the review and corrected the text. MC supervised the writing of the review. All authors contributed to the article and approved the submitted version.

Ethics approval

This review article did not require approval by an Ethics Committee.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Code availability

Not applicable.

Availability of data and materials

Not applicable.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 109 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehnbom, E.C., Berbakov, M.E., Hoffins, E.L. et al. Elevating Safe Use of Over-The-Counter Medications in Older Adults: A Narrative Review of Pharmacy Involved Interventions and Recommendations for Improvement. Drugs Aging 40, 621–632 (2023). https://doi.org/10.1007/s40266-023-01041-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-023-01041-5

Search

Navigation